| |
Benz J, Oshrain C, Henry D, et al. Valsartan, a new angiotensin II receptor antagonist: a double-blind study comparing the incidence of cough with lisinopril and hydrochlorothiazide. J Clin Pharmacol 1997; 37: 101-7 This source discusses a study done rega
Diovan: Implications and Nutrients
Trillou, C., Arnone, M., Delgorge, C., Gonalons, N., Keane, P., Maffrand, J. & Soubrie, P. (2003). Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice. American Journal of Physiology, 284, R345-R353.
Endocannabinoids
Borison RL. "Clinical efficacy of serotonin-dopamine antagonists relative to classic neuroleptics." J Clin Psychopharmacol 1995; 15(Suppl 1): 24S-29S.
Diagnosing and Treating Psychotic Syndromes
Betancur C, Azzi M, Rostene W 1997 Nonpeptide antagonists of neuropeptide receptors. Trends Pharmacol Sci 18: 372-386.
Doperminergic Neurotransmission
van der Lely, A. J. et al. (November 24, 2001). Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist. Lancet, Vol. 358, Issue 9295, p. 1754.
Human Growth Hormone
|
|